Teladoc Health, Inc. (NYSE:TDOC) Stake Increased by Westside Investment Management Inc.

Westside Investment Management Inc. raised its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 37.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,662 shares of the health services provider’s stock after purchasing an additional 1,550 shares during the period. Westside Investment Management Inc.’s holdings in Teladoc Health were worth $85,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. ICA Group Wealth Management LLC bought a new stake in Teladoc Health during the fourth quarter valued at $28,000. Hexagon Capital Partners LLC boosted its holdings in shares of Teladoc Health by 204.4% during the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after acquiring an additional 1,065 shares during the period. RIA Advisory Group LLC acquired a new position in shares of Teladoc Health during the fourth quarter valued at $36,000. GAMMA Investing LLC acquired a new position in shares of Teladoc Health during the fourth quarter valued at $41,000. Finally, Principal Securities Inc. acquired a new position in shares of Teladoc Health during the fourth quarter valued at $45,000. Institutional investors own 76.82% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on TDOC. Oppenheimer reduced their price target on shares of Teladoc Health from $26.00 to $21.00 and set an “outperform” rating for the company in a report on Friday, April 26th. Wells Fargo & Company reduced their price target on shares of Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating for the company in a report on Monday, April 29th. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a report on Friday, April 26th. TD Cowen reduced their price objective on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a report on Friday, April 26th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Teladoc Health from $19.00 to $16.00 and set a “neutral” rating for the company in a report on Tuesday, May 21st. Thirteen equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and a consensus price target of $18.22.

Insiders Place Their Bets

In other Teladoc Health news, insider Laizer Kornwasser sold 10,411 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the sale, the insider now owns 86,070 shares in the company, valued at approximately $1,092,228.30. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Teladoc Health news, insider Laizer Kornwasser sold 10,411 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the sale, the insider now owns 86,070 shares in the company, valued at approximately $1,092,228.30. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Michael Willem Waters sold 5,793 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the sale, the chief operating officer now owns 64,881 shares in the company, valued at approximately $823,339.89. The disclosure for this sale can be found here. In the last quarter, insiders have sold 32,592 shares of company stock worth $397,064. Company insiders own 0.95% of the company’s stock.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $9.25 on Thursday. Teladoc Health, Inc. has a twelve month low of $9.22 and a twelve month high of $30.41. The company has a current ratio of 3.82, a quick ratio of 3.74 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $1.57 billion, a price-to-earnings ratio of -6.56 and a beta of 0.94. The firm has a 50-day moving average of $11.32 and a two-hundred day moving average of $15.51.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. During the same period in the previous year, the company posted ($0.37) earnings per share. Teladoc Health’s revenue was up 2.7% compared to the same quarter last year. As a group, analysts expect that Teladoc Health, Inc. will post -1.05 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.